Precision Medicine at UCSF
Dr. Michael Lesh participated in the panel discussion “Medical Imaging for a Precision Medicine Future” at the 2020 Precision Medicine World Conference.
Targets & Medicines in the Age of the CRISPR
Come to the inaugural LGR Symposium and learn how this lab aims to facilitate and accelerate collaborations between GSK and UC scientists and clinicians.
Digital Health Wins Big at UCSF Awards Event
Anne Wojcicki (23 and Me), Glen Tullman (Livongo), and Sean Duffy (Omada Health) inaugurate the UCSF Digital Health Innovation Hall of Fame.
From the Lab to the Bedside
Join UCSF’s Entrepreneurs in Residence (EIRs) and provide valuable expertise to UCSF’s most promising ideas. More Information to come.
InVest In Ourselves...
The UCSF InVent Fund is open for business! Innovation Ventures supports faculty whose inventions would benefit from licensing to new or established companies with the expertise and funding to develop those further.
UC Announces Collaboration in Data Science Research
New fellowship program facilitated by Johnson & Johnson with UCSF and UC Berkeley to recruit data scientists for data-driven healthcare research.
UC’s CRISPR Expertise to Speed Drug Discovery
Jennifer Doudna and Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.
Exploring a Patient-First Partnership
Scientists at AbbVie and University of California, San Francisco collaborate with patient needs in mind.
Tumor Regression Discovery Gets Green
Once considered an un-druggable target, a novel, small molecule approach to induce tumor regression was discovered by UCSF's Kevan Shokat, Ph.D. Now the FDA has cleared the IND application for clinical development.
Tmunity and UCSF Announce Collaboration
Tmunity agrees to exclusive license and research collaboration with UCSF's Hideho Okada, a physician-scientist and professor of neurological surgery who studies immunotherapeutic strategies aimed at malignant brain tumors.
Scientists Create Speech From Brain Signals
A prosthetic voice decodes what the brain intends to say and generates (mostly) understandable speech, no muscle movement needed.

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...